MANE
Veradermics, IncCompany with tickers: MANE
CIK
1827635
CUSIP
922967104
Shares Outstanding
41,778,687
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $29,862,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $20,925,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-29,862,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-27,232,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-1.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-1.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |